Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
Pitfalls to Avoid in Late-Stage Pharmaceutical Development (and How to Prevent Costly Delays)
Read More
post
What Are the 4 Stages of Drug Development?
Read More
white-paper
The Potential Impact of U.S. Tariffs on the Biotech Sector: Manufacturing, Funding, and Clinical Trials
Read More
post
Leveraging FDA Type A Meetings for Faster Drug Development
Read More
Let's move from science to success.
Let’s Talk